A Multicentric, Comparative Controlled, Randomized, Parallel-Group, Phase III Study to Evaluate the Safety and Efficacy of FDC Containing Rosuvastatin Calcium and Telmisartan on Mild to Moderate Hypertension in Dyslipidemic Patients.

Trial Profile

A Multicentric, Comparative Controlled, Randomized, Parallel-Group, Phase III Study to Evaluate the Safety and Efficacy of FDC Containing Rosuvastatin Calcium and Telmisartan on Mild to Moderate Hypertension in Dyslipidemic Patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Rosuvastatin/telmisartan (Primary) ; Rosuvastatin; Telmisartan
  • Indications Dyslipidaemias; Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Biocon
  • Most Recent Events

    • 07 Mar 2013 Status changed from not yet recruiting to completed as reported by Clinical Trials Registry - India.
    • 17 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top